Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bouwman

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cancer Discovery|July 23, 2013
A high-throughput functional complementation assay for classification of BRCA1 missense variantsPeter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, et al.
Nature Structural & Molecular Biology|November 16, 2010
BRCA2 acts as a RAD51 loader to facilitate telomere replication and cappingSophie Badie, Jose M Escandell, Peter Bouwman, et al.
Nature Communications|July 18, 2017
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cellsPepijn M Schoonen, Francien Talens, Colin Stok, et al.
Toxicology|May 7, 2026
Towards a novel toxicity prediction pipeline, combining PBPK models and mechanistic cellular adversity modelsElsje J Burgers, Raju P Sharma, Tamara Y Danilyuk, et al.
Archives of Toxicology|November 5, 2025
A broad kinase inhibitor library live cell imaging screen using liver, kidney and cardiac hiPSC-ICAM1-eGFP reporter lineages identifies liabilities for TNFα pathway modulationMatthijs Vlasveld, Linda van den Berk, Janet Piñero, et al.
Cancer Research|December 12, 2018
Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient TumorsMarco Barazas, Alessia Gasparini, Yike Huang, et al.
Toxicology|August 1, 2025
Mathematical modelling reveals compound-specific stress pathway activityElsje J Burgers, Tamara Y Danilyuk, Raju P Sharma, et al.
Breast Cancer Research : BCR|May 5, 2023
Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitorsVera E van der Noord, Wanda van der Stel, Gijs Louwerens, et al.
Molecular and Cellular Biology|June 20, 2006
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during developmentLaurens A van Meeteren, Paula Ruurs, Catelijne Stortelers, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer Discovery|July 23, 2013
A high-throughput functional complementation assay for classification of BRCA1 missense variantsPeter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, et al.
Nature Structural & Molecular Biology|November 16, 2010
BRCA2 acts as a RAD51 loader to facilitate telomere replication and cappingSophie Badie, Jose M Escandell, Peter Bouwman, et al.
Nature Communications|July 18, 2017
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cellsPepijn M Schoonen, Francien Talens, Colin Stok, et al.
Toxicology|May 7, 2026
Towards a novel toxicity prediction pipeline, combining PBPK models and mechanistic cellular adversity modelsElsje J Burgers, Raju P Sharma, Tamara Y Danilyuk, et al.
Archives of Toxicology|November 5, 2025
A broad kinase inhibitor library live cell imaging screen using liver, kidney and cardiac hiPSC-ICAM1-eGFP reporter lineages identifies liabilities for TNFα pathway modulationMatthijs Vlasveld, Linda van den Berk, Janet Piñero, et al.
Cancer Research|December 12, 2018
Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient TumorsMarco Barazas, Alessia Gasparini, Yike Huang, et al.
Toxicology|August 1, 2025
Mathematical modelling reveals compound-specific stress pathway activityElsje J Burgers, Tamara Y Danilyuk, Raju P Sharma, et al.
Breast Cancer Research : BCR|May 5, 2023
Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitorsVera E van der Noord, Wanda van der Stel, Gijs Louwerens, et al.
Molecular and Cellular Biology|June 20, 2006
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during developmentLaurens A van Meeteren, Paula Ruurs, Catelijne Stortelers, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Pageof 5